$GNW

McInerney Thomas J sold $927K of GNW

McInerney Thomas J (President and CEO; Director) sold 100,000 shares of GENWORTH FINANCIAL INC (GNW) at $9.27 ($0.93M total) on 2026-05-22.

Original reporting
SEC EDGAR · McInerney Thomas J
Published May 27, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GNW
Neutral
medium confidence
Mentioned
$GNW
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GNWNeutralMed
01

Why it matters

Treat as a sentiment/positioning datapoint rather than a fundamental catalyst; monitor for follow-on insider activity or concurrent company news.

02

Market read

GNW experiences disclosed insider selling (100,000 shares) with no stated fundamental trigger in the article.

03

What to watch

The sale is not stated to be under a 10b5-1 plan, but the filing alone does not reveal intent, whether it was pre-planned via other arrangements, or whether other insiders are buying.

Relevance 7/10Timing: Immediate (filed 2026-05-27; transaction dated 2026-05-22).

Background

The article is an SEC Form 4 insider transaction disclosure for Genworth Financial (GNW).

Company-level read

Ticker impact

$GNWNeutralMedium confidence
Context

Genworth Financial CEO/Director Thomas J. McInerney sold 100,000 shares in an open-market transaction worth $927,000, disclosed via SEC Form 4.

Expected impact

Likely limited near-term impact; any reaction would be modest unless selling accelerates or coincides with other negative news.

Evidence & confidence

This is an ownership-change disclosure only; there is no mention of earnings, guidance, deals, litigation, or regulatory actions. The absence of a 10b5-1 plan reduces interpretive certainty but still doesn’t establish a fundamental change.

Market effects

Minimal; single-insider sale without additional sector/regulatory developments provides little read-across value.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine (taxes, diversification) and may not reflect negative expectations, especially when the article provides no accompanying negative fundamentals.

Key entities

  • GENWORTH FINANCIAL INC

    Subject of the SEC Form 4 insider sale by CEO/Director Thomas J. McInerney.

  • McInerney Thomas J

    President and CEO; Director who sold 100,000 GNW shares for $927,000.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GNWMed

Genworth (GNW) Added $500M to its Repurchase Authorization. Can Enact (ACT) Capital Returns Fund the Buybacks?

Genworth Financial (GNW) increased its share buyback authorization by $500M, bringing total unused capacity to $588M. The move relies on capital returns from its majority-owned subsidiary, Enact Holdings (ACT), which has raised its expected 2026 capital returns to $550M-$600M. GNW has already repurchased 30M shares for $262M under the prior authorization. However, the company faces risks, including dependence on ACT's performance and legacy insurance challenges.

$GNWMed

Genworth leans on mortgage unit, CareScout to offset Q2 LTC liabilities

Genworth Financial reported Q2 net income of $47 million and said it is relying on mortgage insurance Enact and its CareScout aging-care platform to offset long-term care insurance liabilities. CareScout had 1,450 matches in Q2 and expects about $25 million in 2026 CareScout Services revenue. Enact guidance implies $445M to $485M capital returns in 2026. Genworth’s AXA appeal decision is expected in 3 to 6 months.

$GNWMed

Genworth Financial Q2 Earnings Call Highlights

Genworth Financial (NYSE:GNW) discussed Q2 results and capital allocation tied to Enact. Enact’s PMIER sufficiency was 161% (about $1.9B above requirements) and returned $103M of capital to Genworth. GNW raised 2025 capital-return outlook to $445M-$485M and increased 2026 buybacks to $225M-$250M. CareScout network and worksite insurance approvals expanded; closed block loss was $110M adjusted.

$GNWMed

GENWORTH FINANCIAL INC (GNW): Results of Operations and Financial Condition

GENWORTH FINANCIAL INC (GNW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Genworth Financial Announces Second Quarter 2026 Results Strategic Highlights • Strong capital returns from Enact, with $103M received in the quarter • Repurchased $62M of shares in the quarter; $918M since program inception through June 30, 2026 • CareScout delivere